Tmall AI Institute Launches MAOSS Model: Using AI to Screen for Fatty Liver Disease, Doubles High-Risk Detection Rate

Alibaba Tmall AI Institute collaborated with multiple hospitals to develop the AI model MAOSS for screening fatty liver disease, and the research was published in Nature Communications. The model aims to address the challenge of early diagnosis of fatty liver disease, as traditional tests have insufficient sensitivity and high costs, while the prevalence of fatty liver disease is high and it can progress to severe liver diseases.